EnhancerAtlas 2.0: an updated resource with typical enhancer annotation in 600 tissue/cell types across nine species

TagContent
EnhancerAtlas ID
HS091-30751 
Organism
Homo sapiens 
Tissue/cell
HepG2 
Coordinate
chr20:34326930-34328440 
Target genes
TF binding sites/motifs
Number: 2             
TFJASPAR IDCoordinateMotif SequenceStrand-Log10(p-value)
SOX10MA0442.2chr20:34327972-34327983TCCTTTGTTTT-6.32
Sox3MA0514.1chr20:34327973-34327983CCTTTGTTTT+6.02
Number of super-enhancer constituents: 30             
IDCoordinateTissue/cell
SE_10325chr20:34327948-34333134CD19_Primary
SE_11701chr20:34325957-34333474CD20
SE_11971chr20:34326440-34327172CD3
SE_11971chr20:34327785-34332645CD3
SE_12950chr20:34327888-34332257CD34_Primary_RO01480
SE_13519chr20:34326831-34333346CD34_Primary_RO01536
SE_14173chr20:34328140-34332627CD34_Primary_RO01549
SE_14844chr20:34326790-34333215CD4_Memory_Primary_7pool
SE_15618chr20:34327141-34332758CD4_Memory_Primary_8pool
SE_16596chr20:34327965-34332507CD4_Naive_Primary_8pool
SE_17073chr20:34326234-34327180CD4p_CD225int_CD127p_Tmem
SE_17073chr20:34327287-34332570CD4p_CD225int_CD127p_Tmem
SE_17562chr20:34325823-34333102CD4p_CD25-_CD45RAp_Naive
SE_18082chr20:34325797-34332966CD4p_CD25-_CD45ROp_Memory
SE_18974chr20:34325814-34333272CD4p_CD25-_Il17-_PMAstim_Th
SE_19843chr20:34326087-34327119CD4p_CD25-_Il17p_PMAstim_Th17
SE_19843chr20:34327183-34332655CD4p_CD25-_Il17p_PMAstim_Th17
SE_20112chr20:34326032-34332855CD56
SE_21196chr20:34327843-34333150CD8_Memory_7pool
SE_21681chr20:34326231-34332704CD8_Naive_7pool
SE_22255chr20:34327718-34332900CD8_Naive_8pool
SE_22404chr20:34325888-34333008CD8_primiary
SE_26356chr20:34326287-34333061Duodenum_Smooth_Muscle
SE_35274chr20:34326969-34332447HeLa
SE_36873chr20:34326330-34331841HMEC
SE_37789chr20:34327179-34331985HSMMtube
SE_40574chr20:34327194-34327833K562
SE_54011chr20:34327178-34327581Spleen
SE_62768chr20:34326402-34333263Tonsil
SE_65155chr20:34327071-34331820NHEK
Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder
Number of disease enhancers: 1             
ChromosomeStartEnd
chr203432706534327239
Enhancer Sequence
GTTCTCATCC TAAGCAGGGT TGATAGAAGA ACATCATGAG GACGAAGTGG TAACATTTCA 60
AGTTGTCAAA GGGTAAAGGG AACAGGAATA AGAAAATACA AAACAATTTT AAAACTAATT 120
ATTTACTTAT AGTTTAACAT GGAAGGCTAT AAAAAAATTT AGATGGGTAT GTGTTTAACC 180
ACTTTGTTGC TTACATTTAA GTCATCAAGA TACAAAAATA AAAAAATTTT CCATATTAAC 240
ATGTTAAATT TTACTTTCTT ATATAGTTTA GATATTAAAA GTTATCCAGA TTTACAATGT 300
TGAAGTGGTT AAATATAATT TCCATAAAAC ATGAAGTCCT GTTTTGAGTT TTATTCCATG 360
TGCTATGGTC CCTTTGGTCA GTACCATGGC TCTATTTCTG CCTAAGCCCC AAGTGGCCAT 420
GCTAGCAGCC AGCCACTATC GATTTCCTGT GACCGATGCC ATTCCTGAGA TCTTCGCCCA 480
TTTCCGTTGG AGGGTTGGGA CTGTAAGAGC TTGATGCCAC CTCTGTCACA CATCTCGCCC 540
TGAAGCAAAC AGGGATTCAC ACTGCTTTAG TAATGTTGAC TCCCAAGAAC CCAAGAAAGT 600
CAATTAATAA TCCACCAAGT CCAGCCTAAA CATTTCCTAC TTCCATACCT GTTTACATGG 660
AATTACATCC ATGTTAAAAA AAACTAAGAC ACAAGAATCT TAACATTAAA ACAGAAAGTA 720
GCTCTTCAAG AGTCTAAGCA TTACAAAATT ACATACACTA TTTAAATCTA TCAAGAATTC 780
ATCCAAATTG GTACCACATG GTCGTGCTAT ACAATCCAAA ACAAATGTAT TATTTTTAAA 840
AGGTTTAGTG AAATGTTTAT TTTAAAGTTT GATTACATCA GCTATAGGAG TAAAGTGCTA 900
ACTTACAAAG CTTACAGTTT GTGACACCAG TGATAATGCA TGCATACTGC TATTTTCACC 960
ACCAACTGGT GAAACAATGA AAAGACAGTT TACTTTTACT GAGATACCGA AATGAGTCAA 1020
AGACTATATT AGCCAATATA ATTCCTTTGT TTTTAGTGTG AAATACTATG GTAGGGCCTA 1080
ATTAAAAATA AAAACAATAT GGAGAACAGT AAAACAGTCA TCAAGTGACT CTAAGCTTGT 1140
ATTTACTCTA AGCTTGTATT AAGCTTGTAT TGACTCTACT GCCTCTTGTA TTTTTTTTTT 1200
TTAATTTCTA TTCAGGGATC CAAGAATTTT AGTAATTATT AACTGAGCAG CAGATTGCCA 1260
CTGGACTGTT TTAAGATTTA CTATCACCAG TCTTACATAG ATACATAAAT TTTAAAATCT 1320
CACCCATTTC TTCTTATAAG ACTGTTAGAA GATTTAACTT GCCACAGACT GGTCATGCTT 1380
TGTTATTCTT GGACCCCTGC TTTTTCCCAA ACCACTACAT TCACCTTTTT GCTATACCAA 1440
ACTGGAGGTG GTAATTCTTA GTTGAGTCAT TTTACCTAGG GGACCACGGT ACAGCGATAA 1500
GTCACTCAAT 1510